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rc-like adaptor protein (SLAP) down-regulates
expression of the T cell receptor (TCR)–CD3 complex
during a speciﬁc stage of thymocyte development
when the TCR repertoire is selected. Consequently,
SLAP
 
 
 
/
 
 
 
 thymocytes display alterations in thymocyte
development. Here, we have studied the mechanism of
SLAP function. We demonstrate that SLAP-deﬁcient
thymocytes have increased TCR
 
 
 
 chain expression as a
result of a defect in TCR
 
 
 
 degradation. Failure to degrade
S
 
TCR
 
 
 
 leads to an increased pool of fully assembled TCR–
CD3 complexes that are capable of recycling back to the
cell surface. We also provide evidence that SLAP func-
tions in a pathway that requires the phosphorylated
TCR
 
 
 
 chain and the Src family kinase Lck, but not ZAP-
70 (
 
 
 
-associated protein of 70 kD). These studies reveal
a unique mechanism by which SLAP contributes to the
regulation of TCR expression during a distinct stage of
thymocyte development.
 
Introduction
 
T cells develop in the thymus, where immature thymocytes
undergo a developmental program that ensures the generation
of T cells with a diverse repertoire of T cell receptors (TCRs).
These TCRs are capable of recognizing foreign antigens that are
presented by major histocompatibility complex (MHC) molecules
without being autoreactive (Love and Chan, 2003). The 
 
  
 
TCR
is part of a multichain complex that is composed of the peptide–
MHC-binding TCR
 
 
 
 and 
 
 
 
 chains that are noncovalently asso-
ciated with the CD3
 
    
 
 and TCR
 
  
 
 chains, which together are
referred to as the CD3 complex (Exley et al., 1991). Although
 
  
 
TCR is responsible for antigen recognition, the remainder of
the CD3 complex—the TCR
 
 
 
 chains in particular—is required
for coupling the TCR to downstream signaling molecules.
Generation of the 
 
  
 
TCR repertoire is initiated at the
most immature stage of thymocyte development (Sebzda et al.,
1999). At this early stage of development, thymocytes express
neither CD4 nor CD8 coreceptors. Thymocytes that are des-
tined to become 
 
  
 
 T cells stochastically rearrange their TCR
 
 
 
genes. If rearrangement of TCR
 
 
 
 is successful (in frame), the
TCR
 
 
 
 chain is transported together with a nonvariant pre-
TCR
 
 
 
 chain and the CD3 complex to the cell surface as the
pre-TCR complex. Surface expression of the pre-TCR complex
induces ligand-independent signals (Irving et al., 1998), which
allows for thymocytes to proliferate and up-regulate CD4
and CD8 expression, thereby progressing to the CD4
 
  
 
CD8
 
 
 
double-positive (DP) stage of development. At the DP stage of
development, thymocytes rearrange their TCR
 
 
 
 genes. If the
rearrangement of TCR
 
 
 
 is successful, low levels of the mature
TCR–CD3 complex are expressed on the surface of the devel-
oping thymocyte. Expression of the TCR–CD3 complex is
crucial at this stage of development, as signals through the
TCR are required for the survival (positive selection) or deletion
(negative selection) of DP thymocytes (Sebzda et al., 1999;
Love and Chan, 2003). If the TCR expressed by a DP thymocyte
cannot bind to self-peptide–MHC molecules, the thymocyte
fails to receive positively selecting signals and subsequently
dies. Conversely, if the TCR interacts too strongly with self-
peptide–MHC molecules, the cell is potentially autoreactive
and is deleted via apoptosis. Thymocytes that express TCRs
with an intermediate affinity for peptide–MHC down-regulate
either CD4 or CD8, thereby progressing to the single-positive
(SP) stage of development. Progression to this more pheno-
typically and functionally mature SP stage is also associated
with a 10-fold increase in the level of the TCR–CD3 complex to
that of mature peripheral T cells. At the SP stage, thymocytes
are subjected to further selection and maturation processes
before exiting the thymus as mature T cells.
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Both positive and negative selection processes are depen-
dent on the strength of signals received through the TCR–CD3
complex. Signal strength is dependent not only on the intrinsic
affinity of the TCR for peptide–MHC molecules but also on the
number of receptors that interact with peptide–MHC. TCR–
CD3 expression on DP thymocytes is only 
 
 
 
10% of the level
observed on SP thymocytes and mature T cells (Finkel et al.,
1987; Havran et al., 1987). Previous studies have demonstrated
that modulating levels of TCR–CD3 expression in developing
thymocytes can lead to alterations in positive selection (Erics-
son and Teh, 1995; Naramura et al., 1998; Sosinowski et al.,
2001), suggesting that tight regulation of surface TCR–CD3
levels is required for normal TCR repertoire selection. There-
fore, proteins that regulate surface TCR–CD3 levels in the thy-
mus are likely to be important determinants of thymocyte de-
velopment.
Recently, we have shown that Src-like adaptor protein
(SLAP) regulates the level of TCR–CD3 expression on DP thy-
mocytes (Sosinowski et al., 2001). SLAP was identified in a
yeast two-hybrid screen for proteins that interact with the cyto-
plasmic domain of the Eck receptor protein tyrosine kinase
(Pandey et al., 1995). In particular, SLAP is highly homologous
with Src family kinases, which include the T lymphocyte–spe-
cific family members of Lck. Like Src family kinases, SLAP has
a unique NH
 
2
 
 terminus that is myristolated, thereby targeting
SLAP to cellular membranes (Manes et al., 2000). The NH
 
2
 
 ter-
minus of SLAP is followed by Src homology (SH) 3 and 2 do-
mains, which share 55 and 50% amino acid sequence identity
with these domains in Lck, respectively. Unlike Src family ki-
nases, however, SLAP lacks a kinase domain and, instead, con-
tains a unique COOH terminus, whose function remains unclear.
Because SLAP is highly homologous to Lck but lacks a
kinase domain, it was postulated that SLAP could negatively
regulate Src family kinases by functioning in a dominant nega-
tive manner. Overexpression and microinjection studies in non-
lymphoid cells have shown that SLAP can inhibit Src-mediated
signaling through the platelet-derived growth factor receptor
(Roche et al., 1998; Manes et al., 2000). In Jurkat T cells, the
transient overexpression of SLAP can inhibit signaling down-
stream of the TCR as measured by nuclear factor of activated T
cells, AP-1, or interleukin 2 transcriptional reporter activity
(Sosinowski et al., 2000). Maximum inhibition of nuclear fac-
tor of activated T cell activity in Jurkat T cells requires both the
SH2 and SH3 domains of SLAP. Altogether, these data suggest
that SLAP is an inhibitor of Src family kinases. However, the
mechanism by which SLAP inhibits signaling remains unclear,
as no differences in overall tyrosine phosphorylation were
observed in Jurkat T cells that overexpressed SLAP or in
SLAP
 
 
 
/
 
 
 
 thymocytes (Sosinowski et al., 2000, 2001).
In mice, SLAP protein expression is developmentally re-
stricted and is most highly expressed in DP thymocytes (Sosi-
nowski et al., 2001). Consistent with this restricted pattern of
expression, targeted inactivation of the SLAP gene demon-
strated that SLAP down-regulates TCR–CD3 expression at the
DP stage of thymocyte development. In addition to increased
TCR–CD3 expression, SLAP
 
 
 
/
 
 
 
 DP thymocytes also display
increased levels of CD4, CD5, and CD69. Furthermore,
SLAP
 
 
 
/
 
 
 
 thymocytes display increases in positive selection
in the presence of a transgenic TCR. Finally, SLAP deficiency
can partially overcome a developmental block at the DP stage
and rescue the development of CD4
 
 
 
 SP thymocytes and pe-
ripheral T cells in mice that lack ZAP-70 (
 
 
 
-associated protein
of 70 kD) tyrosine kinase. These alterations in thymocyte de-
velopment in the absence of SLAP argue that control of surface
TCR–CD3 levels on DP thymocytes is an important regulatory
step in the generation of peripheral T cells. Therefore, we set
out to elucidate the mechanism of SLAP-mediated TCR–CD3
down-regulation on DP thymocytes. In this study, we show that
SLAP-deficient thymocytes have a defect in TCR
 
 
 
 chain deg-
radation, which leads to an increased pool of fully assembled
TCR–CD3 complexes that are capable of recycling back to the
cell surface.
 
Results
 
Total levels of TCR
 
 
 
 are increased in 
SLAP
 
 
 
/
 
 
 
 DP thymocytes
 
SLAP
 
 
 
/
 
 
 
 mice have increased levels of surface TCR–CD3 on
DP thymocytes (Fig. 1 C; Sosinowski et al., 2001). We rea-
soned that if either synthesis or degradation is altered by the
Figure 1. TCR  chain expression is increased
in SLAP /  mice. (A) Western blot analysis
of TCR , CD3 , and TCR  expression in RIPA
lysates of purified CD8  thymocytes from WT
and SLAP /  mice. Data are representative
of six independent experiments. (B) Quantitation
of Western blots represented in A using quan-
titative luminescence. Data represent mean
expression of TCR , CD3 , or TCR  by
SLAP /  CD8  thymocytes as compared
with WT controls   SEM. TCR–CD3 levels
have been normalized to  -tubulin. (C) Surface
or total TCR  and CD3  expression by either
surface or intracellular FACS staining. Data
are representative of six mice per genotype.
(D) Quantitation of FACS staining shown in C.
Data represent the mean fluorescence intensity
(MFI)   SEM (error bars) as compared with
WT controls for six mice of each genotype. 
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absence of SLAP, total levels of TCR–CD3 should also be up-
regulated. Total cell lysates were prepared from CD8
 
 
 
 thy-
mocytes, which contained mostly DP thymocytes but also con-
tained small numbers of CD8
 
 
 
 SP thymocytes. Purified cells
were 
 
 
 
95% DP, as determined by FACS (unpublished data).
By Western blot analysis, total levels of the TCR
 
 
 
 chain were
consistently increased three- to fourfold in SLAP
 
 
 
/
 
 
 
 CD8
 
 
 
thymocytes as compared with wild-type (WT) controls (Fig. 1,
A and B). In contrast, total levels of TCR
 
 
 
 and CD3
 
 
 
 were not
substantially increased. Although lysates contained mostly DP
thymocytes, there was a small (
 
 
 
5%) contaminating pool of
CD8
 
 
 
 SP thymocytes in lysate preparations. Therefore, we
used intracellular FACS staining to analyze total TCR–CD3
levels, specifically in DP thymocytes (Fig. 1, C and D). We
were unable to stain for the TCR
 
 
 
 chain by FACS, but intracel-
lular FACS analysis confirmed the results that were obtained
by Western blot analysis for CD3
 
 
 
. Although surface levels of
CD3
 
 
 
 (as well as TCR
 
 
 
) were consistently three- to fivefold
higher on SLAP
 
 
 
/
 
 
 
 DP thymocytes, total levels of TCR–CD3
were not significantly increased.
Increased TCR
 
 
 
 chain expression in the absence of SLAP
suggests that SLAP modifies the rate of TCR
 
 
 
 synthesis and/or
degradation. Metabolic labeling of CD8
 
 
 
 thymocytes demon-
strated that the synthesis of TCR
 
 
 
, TCR
 
 
 
, and CD3
 
 
 
 during a
30-min pulse label was similar in WT and SLAP
 
 
 
/
 
 
 
 thy-
mocytes (Fig. 2 A). To test whether the rate of TCR
 
 
 
 degrada-
tion was altered in the absence of SLAP, thymocyte single-cell
suspensions that were enriched for DP thymocytes (CD8
 
 
 
 pu-
rified) were treated with cycloheximide to inhibit synthesis of
TCR chains, and the stability of CD3
 
 
 
, TCR
 
 
 
, and TCR
 
 
 
 over
time was assessed by either Western blot analysis or by intra-
cellular FACS staining. Degradation of TCR
 
 
 
, but not CD3
 
 
 
,
TCR
 
 
 
, or TCR
 
 
 
, was markedly impaired in SLAP
 
 
 
/
 
 
 
 thy-
mocytes as compared with WT controls (Fig. 2, B–D). We
were unable to study TCR
 
 
 
 and TCR  degradation using a
FACS-based assay. Therefore, we simultaneously investigated
CD3  degradation by intracellular FACS staining to determine
whether the results obtained by Western blot analysis of
CD8 -purified thymocytes were similar to the results obtained
by intracellular FACS staining of DP thymocytes. CD3  degra-
dation by Western blot analysis was comparable to the FACS-
based assay (Fig. 2, B–D), demonstrating that contamination
from SP thymocytes does not significantly contribute to the im-
paired degradation of TCR  that was observed in SLAP / 
thymocytes.
Recycling TCR–CD3 complexes are 
increased in the absence of SLAP
The failure of SLAP /  thymocytes to degrade TCR  may be
a result of alterations in the dynamics of TCR–CD3 internaliza-
tion and/or recycling. However, SLAP /  DP thymocytes
that were precoated with anti-CD3  mAbs internalized surface-
bound mAb with kinetics similar to WT thymocytes (Fig. 3 A).
Next, we tested whether SLAP regulates recycling of the TCR–
CD3 complex. Thymocytes were incubated in culture with
phycoerythrin (PE)-labeled anti-CD3  mAb for 30 min at 37 C
to label an internalized pool of CD3 . Cells were transferred to
ice and washed, and surface-bound antibody was removed by
using two sequential low pH washes. Thymocytes were then
resuspended in cell culture medium and were incubated at 37 C
for various time points. Anti-CD3  mAb that recycled back to
the cell surface during the course of the assay was removed by
a second series of low pH washes. The amount of CD3 –PE
fluorescence that was lost as compared with staining of the in-
tracellular pool at time 0 was used to calculate the percentage
of CD3  recycled at each time point. SLAP-deficient DP thy-
mocytes recycled CD3  more rapidly than DP thymocytes
from WT mice (Fig. 3 B). Furthermore, SLAP-deficient DP
thymocytes recycled more CD3  over the course of the assay,
suggesting that the size of the CD3  recycling pool is increased
in the absence of SLAP. Notably, the increase in CD3  recy-
cling was seen only in DP thymocytes, where SLAP is most
highly expressed, because CD3  recycling by SP thymocytes
was similar regardless of genotype.
Next, we tested whether the size of the CD3  recycling
pool is altered in the absence of SLAP. We were unable to mea-
Figure 2. TCR  degradation is impaired in
SLAP /  thymocytes. (A) TCR , CD3 , and
TCR  immunoprecipitates from WT and
SLAP /  thymocytes after 30 min of meta-
bolic labeling with radiolabeled (
35S) cysteine
and methionine. TCR  /  thymocytes were
used as a control for TCR  expression. Data
are representative examples of three indepen-
dent experiments. (B) Degradation of TCR ,
CD3 , and TCR  by WT and SLAP / 
CD8  thymocytes treated with cycloheximide
(CHX), as assessed by Western blot analysis
of RIPA lysates. Data are representative of up
to four independent experiments. (C) Quanti-
tation of Western blots shown in B. Data are
plotted as the mean percent expression rela-
tive to time 0 and are the mean of three mice
per genotype   SEM (error bars). (D) Degra-
dation of TCR  or CD3  in the presence of
cycloheximide by DP thymocytes, as assessed
by intracellular FACS staining.JCB • VOLUME 170 • NUMBER 2 • 2005 288
sure the size of the TCR–CD3 recycling pool by using Fab frag-
ments, presumably as a result of the low level of CD3  expres-
sion in DP thymocytes as compared with background staining
and lower biotin labeling of the Fab fragments. Therefore, thy-
mocytes were incubated with PE-labeled anti-CD3  mAb either
on ice to label only surface CD3  or at 37 C for 60 min to label
both surface CD3  and CD3  that recycled to the cell surface
during the 60-min incubation. More recycling CD3  was la-
beled in SLAP /  DP thymocytes than in WT (Fig. 3 C), indi-
cating that the number of mature TCR–CD3 complexes present
in the recycling pool is increased in the absence of SLAP. In
contrast, the size of the CD3  recycling pool was more similar
to SP thymocytes, suggesting that (consistent with its expres-
sion in DP thymocytes) SLAP regulates the size of the recycling
pool specifically at the DP stage of thymocyte development.
Our lab has previously shown that SLAP-mediated TCR–
CD3 down-regulation on DP thymocytes does not depend on a
positively selecting MHC allele (Sosinowski et al., 2001).
Therefore, we were interested in studying CD3  recycling in the
absence of any TCR ligation. We reasoned that if we could
block internalization of the TCR–CD3 complex, any new TCR–
CD3 appearing on the cell surface would be caused by newly
synthesized or recycled TCR–CD3. To block TCR–CD3 inter-
nalization, we exploited the observation that TCR is internalized
via clathrin-coated pits (Telerman et al., 1987). Hypertonic me-
dium (e.g., 0.45 M sucrose) blocks clathrin-mediated endocyto-
sis by inducing spontaneous clathrin lattice formation in the ab-
sence of cell membranes, thereby depleting the cell of clathrin
monomers that would be used in vesicle formation (Daukas and
Zigmond, 1985; Heuser and Anderson, 1989). Furthermore, hy-
pertonic medium has been shown to inhibit internalization of
the TCR–CD3 complex (Dallanegra et al., 1988).
To validate the use of hypertonic medium to inhibit
TCR–CD3 internalization, we first analyzed the uptake of fluo-
rescently labeled transferrin by the transferrin receptor, a pro-
cess that requires clathrin-mediated endocytosis (Mellman,
1996; Schmid, 1997). Because DP thymocytes do not express
the transferrin receptor, we first tested the effect of hypertonic
medium on Jurkat T cell lines that stably expressed either
SLAP-GFP fusion or GFP alone as a control. Transferrin up-
take via the transferrin receptor was completely inhibited by
hypertonic medium in both stable cell lines (Fig. 4 A), demon-
strating that hypertonic medium blocks clathrin-mediated en-
docytosis regardless of whether SLAP is present or not. We
analyzed the effect of SLAP on CD3  expression while clath-
rin-mediated endocytosis was blocked in Jurkat T cells. Strik-
ingly, we were able to detect up-regulation of CD3  surface ex-
pression over the time course of the experiment in the control
cell line. However, up-regulation of CD3  by Jurkat T cells was
markedly inhibited in the presence of SLAP (Fig. 4 B).
To investigate whether SLAP expression affects up-regu-
lation of CD3  on DP thymocytes as it did in our model cell
line, we incubated thymocyte single-cell suspensions in hyper-
tonic medium and followed CD3  expression over time. Both
WT and SLAP /  DP thymocytes up-regulate CD3  on the
cell surface over the course of the assay (Fig. 4 C). However,
quantitation demonstrated that CD3  up-regulation was sub-
stantially increased in SLAP /  DP thymocytes as compared
with WT controls (Fig. 4 D). Interestingly, the observed up-
regulation of CD3  in hypertonic medium is comparable with
the estimated amount of CD3  present in the recycling pool
(Fig. 3 C), indicating that increases in the size of the TCR–CD3
recycling pool can be revealed upon incubation of thymocytes
in hypertonic medium. Notably, the uptake of fluorescently la-
beled transferrin by double-negative thymocytes (which ex-
press low, but detectable, levels of the transferrin receptor) was
inhibited in the presence of hypertonic medium (unpublished
data), indicating that hypertonic medium inhibited clathrin-
mediated endocytosis in our thymocyte cultures.
Figure 3. Increased TCR–CD3 recycling in SLAP / . (A) Ligand-induced
internalization of CD3  from WT or SLAP /  thymocytes that were
precoated with biotinylated anti-CD3  mAb. CD3  remaining on the cell
surface was detected by staining with PE-streptavidin (SA-PE). (B) Recycling
of previously internalized anti-CD3  antibody by WT and SLAP / 
thymocytes. Data are presented as a percentage of total CD3  internalized
at t   0. (C) Comparison of surface CD3  with the total recycling pool
of CD3 . The surface and recycling pools were labeled by incubating
thymocytes with a PE anti-CD3  antibody for 60 min on ice or at 37 C,
respectively. All data were determined by FACS and represent three mice
per genotype   SEM (error bars).SLAP TARGETS TCR  FOR DEGRADATION • MYERS ET AL. 289
Previous studies have reported that prolonged culture of
DP thymocytes in the absence of TCR–MHC interactions re-
sults in up-regulation of the TCR–CD3 complex by the stabi-
lization of newly synthesized TCR  chains (Bonifacino et
al., 1990; Kearse et al., 1995). Indeed, both WT and SLAP / 
DP thymocytes up-regulate CD3  when cultured in the ab-
sence of 0.45 M sucrose (Fig. 4 E). However, over this time
course, the increase in CD3  expression was markedly lower
than the increase observed in thymocytes that were incubated
in hypertonic medium. In addition, most of the CD3  up-reg-
ulation that was observed in hypertonic medium was detected
after only 2 h in culture, a time at which little or no CD3  up-
regulation had yet occurred in the absence of 0.45 M sucrose.
Furthermore, incubation of thymocytes in cycloheximide to
inhibit protein synthesis had no effect on the up-regulation of
CD3  in hypertonic medium (Fig. 4 D). In contrast, in paral-
lel experiments using thymocytes cultured in media without
0.45 M sucrose, up-regulation of CD3  was sensitive to
cycloheximide treatment (unpublished data), demonstrating
that cycloheximide effectively inhibited protein synthesis in
our cultures.
It is possible that incubation of thymocytes in hyper-
tonic medium has an effect on cell viability. However, An-
nexin V staining failed to demonstrate a decrease in thy-
mocyte viability for thymocytes incubated in hypertonic
medium (unpublished data). In addition, because SLAP pro-
tein expression is predominantly restricted to DP thymocytes
(Sosinowski et al., 2001), up-regulation of CD3  in hyper-
tonic medium should not be altered in SP thymocytes. Nota-
bly, CD3  up-regulation by CD4  SP thymocytes that were
cultured in hypertonic medium was similar regardless of ge-
notype (Fig. 4 D). These data demonstrate that up-regulation
of TCR–CD3 expression in hypertonic medium can be used to
analyze the pool of recycling TCR–CD3 complexes in the ab-
sence of receptor cross-linking.
The TCR  chain is the target of SLAP
We have demonstrated that expression of TCR  is increased in
SLAP /  thymocytes as a result of the impaired degradation
of TCR . A SLAP-GST fusion has previously been shown to in-
teract with several phosphoproteins, including the TCR  chain
(Tang et al., 1999; Sosinowski et al., 2000). Therefore, we pos-
tulated that SLAP could bind to TCR , leading to its subsequent
degradation. To study the interaction between SLAP and TCR ,
we first examined Jurkat T cells that had been transiently trans-
fected with SLAP-GFP to determine whether SLAP can interact
with the endogenous TCR  chain. SLAP-GFP, but not the GFP
control, coimmunoprecipitated with TCR  (Fig. 5 A). Further-
more, SLAP-GFP containing a point mutation in the SH2 do-
main coimmunoprecipitated only weakly with TCR . The cyto-
plasmic domain of TCR  is phosphorylated by Lck (Iwashima
et al., 1994; van Oers et al., 1996). Therefore, the inhibition of
Src family kinase catalytic activity with PP2 caused a loss of
basal TCR  phosphorylation in Jurkat T cells (Fig. 5 A). Inter-
estingly, PP2 treatment also caused a corresponding loss in
SLAP-GFP coimmunoprecipitation with TCR . The depen-
dence on Src family kinase activity prompted us to study
whether SLAP can interact with TCR  in the Lck-deficient Jur-
kat T cell line JCaM1. Transiently transfected SLAP-GFP failed
to coimmunoprecipitate with TCR  in JCaM1; however, stable
reconstitution of Lck back into the JCaM1 cell line resulted in
the restoration of basal phospho-TCR  as well as the recovery
of SLAP-GFP coimmunoprecipitation with TCR  (Fig. 5 B).
In addition to TCR , SLAP-GST has also been shown to
interact with phosphorylated ZAP-70 (Tang et al., 1999; Sosi-
nowski et al., 2000). ZAP-70 is also phosphorylated by Lck
and can bind to the phosphorylated TCR  cytoplasmic domain
(Iwashima et al., 1994; van Oers et al., 1996). Therefore,
SLAP-GFP may indirectly interact with TCR  via ZAP-70.
However, transiently transfected SLAP-GFP also coimmuno-
precipitated with TCR  in the ZAP-70–deficient Jurkat T cell
Figure 4. Increased TCR–CD3 recycling is re-
vealed in hypertonic medium. (A) Uptake of
Alexa647-labeled transferrin by Jurkat T cell
lines expressing SLAP-GFP or control (GFP) in
the presence or absence of hypertonic medium,
as assessed by FACS. (B) Expression of CD3 
on Jurkat T cell lines expressing SLAP-GFP or
control (GFP) incubated in hypertonic medium,
as assessed by FACS. Data are presented as
the absolute increase in CD3  MFI expression
relative to time 0. Data in A and B are the
mean of three experiments   SEM. (C) CD3 
expression on WT or SLAP /  thymocytes in-
cubated in hypertonic medium for 0 or 6 h, as
assessed by FACS. Data are representative of
three mice per genotype. (D) MFI of CD3 
expression on WT or SLAP /  thymocytes
incubated in 0.45 M hypertonic medium for
the indicated time in the presence or absence
of cycloheximide (CHX). (E) MFI of CD3  ex-
pression on WT or SLAP /  DP thymocytes
incubated for the indicated time in cell culture
medium only. Data in D and E are the mean of
three mice per genotype   SEM (error bars).JCB • VOLUME 170 • NUMBER 2 • 2005 290
line P116 (Fig. 5 C), indicating that the interaction between
phosphorylated TCR  and SLAP-GFP does not require ZAP-
70 and may instead be a direct interaction. Furthermore, neither
surface TCR–CD3 expression (Negishi et al., 1995; Kadlecek
et al., 1998) nor the up-regulation of CD3  by DP thymocytes
that were incubated in hypertonic medium (Fig. 5 E) were in-
creased in the absence of ZAP-70, suggesting that ZAP-70 is
not required for SLAP-mediated down-regulation of the TCR–
CD3 complex in vivo.
It has previously been shown that upon transient transfec-
tion, SLAP localizes to an intracellular compartment and dis-
plays partial colocalization with late endosomes (Sosinowski et
al., 2000). Therefore, we predicted that SLAP would colocalize
with TCR  in an intracellular compartment. Extensive colocal-
ization of SLAP-GFP with endogenous TCR  was observed af-
ter transient transfection into Jurkat T cells (Fig. 5 D). Colocal-
ization occurred primarily in an intracellular compartment, as
very little SLAP-GFP was detected at the plasma membrane.
Interestingly, colocalization requires the SH2 domain of SLAP,
as an SH2 point mutation of SLAP-GFP displayed very little
colocalization with the TCR  chain. These data suggest that the
SH2 domain of SLAP is required for SLAP to interact with
phosphorylated TCR , thus targeting TCR  for degradation.
To investigate the requirement of TCR  cytoplasmic do-
mains for the effects of SLAP on TCR expression in vivo, we
obtained TCR -deficient mice that were reconstituted with
transgenes encoding either full-length TCR  (TCR  Tg) or a
cytoplasmic truncation of TCR  (TCR  D67–150; Shores et
al., 1994). TCR  D67–150 is a deletion of amino acid residues
67–150 of TCR , resulting in the loss of five out of six tyro-
sines that are normally present in the TCR  cytoplasmic do-
main. Interestingly, relative to mice expressing TCR  Tg, mice
expressing TCR  D67–150 displayed increased surface levels
of TCR  and CD3  on DP, but not SP, thymocytes (Fig. 5 F
and not depicted). Furthermore, mice expressing the truncated
form of TCR  displayed increased CD3  up-regulation in hy-
pertonic medium on DP, but not SP, thymocytes (Fig. 5 G),
suggesting that the TCR–CD3 recycling pool is increased in
the absence of the TCR  cytoplasmic domain. The observed in-
crease was not caused by new synthesis of the complex, as cy-
cloheximide had no effect on TCR–CD3 recycling in hyper-
tonic medium (unpublished data). Additionally, no significant
increase in CD3  expression was observed in thymocytes that
were incubated in the absence of 0.45 M sucrose (unpublished
data). These data indicate that the cytoplasmic domain of TCR 
is required to prevent the accumulation of fully assembled
TCR–CD3 complexes in the recycling pool of DP thymocytes.
Discussion
We have studied the mechanism by which TCR–CD3 expres-
sion is increased in the absence of SLAP. Our data demonstrate
Figure 5. SLAP interacts with phospho-TCR  via the SLAP SH2 domain. (A) Immunoprecipitates of endogenous TCR  from Jurkat T cells transiently transfected
with GFP (V), SLAP-GFP (WT), or SH2-GFP (SH2*) as assessed by Western blot analysis. Half of each transfection was pretreated with the Src family
kinase inhibitor PP2 before immunoprecipitation (IP). WCL, whole cell lysate. (B) Immunoprecipitates of TCR  from JCaM1 (Lck / ) or JCaM1 stably
reconstituted with Lck, as assessed by Western blot analysis. Cell lines were transiently transfected with either GFP or WT-GFP. Dividing lines have been
placed to indicate where irrelevant lanes were deleted from the figure. Phospho-TCR  observed in A and B reflects basal TCR  phosphorylation that is
present in unstimulated cells. (C) Immunoprecipitates of TCR  from the ZAP-70 /  Jurkat T cell line P116 transfected with GFP or SLAP-GFP, as assessed
by Western blot analysis. (D) Localization of GFP fluorescence (green) and endogenous TCR  (red) in Jurkat T cells that were transiently transfected with
GFP, SLAP-GFP, or SH2-GFP as analyzed by deconvolution microscopy. Data are representative of  10 cells analyzed per transfection for three independent
experiments. (E) MFI of CD3  expression on ZAP-70 /  DP thymocytes incubated in hypertonic medium. Data are the mean of three mice of each
genotype   SEM. Thymocytes from one WT and one SLAP /  mouse were used for comparison. (F) FACS analysis of CD3  expression on DP and SP
thymocytes in the presence (TCR  Tg) or absence (TCR  D67–150) of most of the TCR  cytoplasmic domain. Histograms are representative of three mice
per genotype. (G) MFI of CD3  expression on DP and SP thymocytes expressing full-length (TCR  Tg) or a cytoplasmic truncation (TCR  D67–150) of the
TCR  cytoplasmic domain that was incubated in hypertonic medium (as assessed by FACS). Data are the mean of three mice per genotype   SEM.SLAP TARGETS TCR  FOR DEGRADATION • MYERS ET AL. 291
that SLAP /  thymocytes have increased TCR  expression as
a result of a defect in TCR  degradation. Failure to degrade
TCR  leads to an accumulation of fully assembled TCR–CD3
complexes that continue to recycle back to the plasma mem-
brane instead of being retained and/or degraded. In addition,
we have shown that Lck, but not ZAP-70 activity, is required
for SLAP to interact with the phosphorylated form of TCR . It
has previously been shown that TCR  is basally phosphory-
lated in DP thymocytes (Nakayama et al., 1989; van Oers et al.,
1994) and that TCR  phosphorylation is almost undetectable in
Lck /  thymocytes (van Oers et al., 1996). Interestingly, sur-
face TCR–CD3 expression is also up-regulated in Lck /  DP
thymocytes (Molina et al., 1992), suggesting that the inability
of SLAP to bind TCR  may contribute to the increase in TCR–
CD3 expression that was observed on Lck /  DP thymocytes.
Thus, SLAP regulates the expression of TCR on DP thy-
mocytes by targeting tyrosine-phosphorylated TCR  for degra-
dation in an Lck-dependent manner.
In addition to Lck, our studies suggest that regulation of
TCR–CD3 expression by SLAP requires the cytoplasmic do-
main of TCR . TCR -deficient mice that are transgenic for a
truncated form of TCR  (TCR  D67–150) express increased
levels of surface TCR–CD3 as well as an increased pool of re-
cycling CD3  on DP, but not SP, thymocytes. It is possible that
in the absence of the majority of TCR  cytoplasmic domains,
trafficking of the TCR–CD3 complex is altered such that inter-
nalization and/or recycling of the complex leads to the pheno-
type that we have observed in TCR  D67–150 DP thymocytes
via a SLAP-independent mechanism. Notably, the TCR  cyto-
plasmic domain contains multiple tyrosine-based motifs that
could mediate internalization of the TCR–CD3 complex. How-
ever, a recent study demonstrated that the mutation of all six ty-
rosines present in the TCR  cytoplasmic domain had no effect
on the internalization of the TCR–CD3 complex (Szymczak and
Vignali, 2005). An additional study has indicated that a similar
deletion of the TCR  cytoplasmic domain increases the rate of
TCR–CD3 internalization (D’Oro et al., 2002). This later study
suggests that, if anything, TCR–CD3 expression should be de-
creased in the absence of the TCR  cytoplasmic domain. None-
theless, we cannot exclude the possibility that altered trafficking
of the TCR–CD3 complex either contributes to or is responsible
for the increased surface TCR–CD3 expression and increased
pool of recycling CD3  in TCR  D67–150 DP thymocytes.
However, our findings are also consistent with a role for the
phosphorylated TCR  cytoplasmic domain interacting with
SLAP, thereby leading to its accelerated degradation.
Previous data indicate that unassembled TCR  chains are
rapidly degraded in the ER of DP thymocytes (Bonifacino et
al., 1990) and that newly synthesized TCR  chains are stabi-
lized by their incorporation into fully assembled TCR–CD3
complexes (Kearse et al., 1995). This raised the possibility that
SLAP could function to prevent assembly of the TCR–CD3
complex. Currently, it is believed that the rate of TCR–CD3 as-
sembly is low in DP thymocytes as a result of the instability of
the TCR  chain. However, because we failed to detect a differ-
ence in expression, synthesis, or degradation of the TCR 
chain in the absence of SLAP, we must conclude that SLAP
does not regulate assembly of the TCR–CD3 complex by the
mechanism previously described. In addition, our data clearly
demonstrate that SLAP interacts with the phosphorylated
TCR  chain, which has been shown to be present only in fully
assembled, mature TCR–CD3 complexes (Kearse et al., 1993).
Therefore, it is unlikely that SLAP plays a direct role in the as-
sembly of TCR–CD3. We cannot exclude the possibility that
SLAP somehow regulates TCR–CD3 assembly through an in-
direct mechanism that has yet to be described. However, our
data suggests that a substantial proportion of TCR  is present
mainly in fully assembled TCR–CD3 complexes, as evidenced
by the large increase in TCR  chain protein expression in WT
thymocytes as compared with TCR  /  thymocytes (Fig. 1
A). Together, these data strongly indicate that the degradation
of TCR  observed in WT DP thymocytes is predominantly
caused by the degradation of TCR  that was derived from fully
assembled TCR–CD3 complexes.
The TCR has been shown to undergo constitutive internal-
ization in cell lines and T cells, with an estimate of 0.6–1.2% of
TCRs internalized per minute (Liu et al., 2000; Menne et al.,
2002). Therefore, subtle modifications to the rate of recycling or
internalization could have large effects on the steady-state level
of TCR expression on the cell surface. We consistently ob-
served an increase in both the rate as well as the absolute
amount of CD3  recycled by SLAP /  DP thymocytes. Nota-
bly, the increased amount of CD3  recycled (5–9% as calcu-
lated from Fig. 3 B) is consistent with the 5–7.5% of TCR 
chains that are estimated to be phosphorylated in the thymus
(van Oers, N., personal communication). Furthermore, the small
difference in CD3  recycling can account for the loss of TCR 
that is observed over time in WT but not for SLAP /  thy-
mocytes when incubated in cycloheximide. Therefore, SLAP
appears to target only a small proportion of the constitutively
recycling TCR–CD3 complexes that contain phospho-TCR .
However, this has a substantial effect on the steady-state level
of TCR–CD3 expression in SLAP-deficient thymocytes.
In contrast to TCR , we were unable to detect a substan-
tial increase in the level of TCR , TCR , or CD3  in the ab-
sence of SLAP. Likewise, degradation of TCR , TCR , and
CD3  was not noticeably altered in the absence of SLAP. One
possible explanation for these observations is that DP thy-
mocytes typically express a relatively large intracellular pool
of unassembled and/or partially assembled TCR–CD3 chains,
some of which are rapidly degraded (Chen et al., 1988; Lippin-
cott-Schwartz et al., 1988; Bonifacino et al., 1989, 1990).
Therefore, the large pools of unassembled TCR–CD3 chains
could mask any differences in TCR–CD3 expression or deg-
radation. Alternatively, our results could also be interpreted
to indicate that TCR  separates from the rest of the mature
TCR–CD3 complex and is independently degraded via a
SLAP-dependent mechanism. Separation of the TCR–CD3
complex has been previously described (Kishimoto et al., 1995;
Ono et al., 1995; Thien et al., 2003; La Gruta et al., 2004). Ad-
ditional studies will be required to conclusively determine
whether the remainder of the recycling TCR–CD3 complex is
also degraded via a SLAP-dependent mechanism or is retained
in an intracellular compartment.JCB • VOLUME 170 • NUMBER 2 • 2005 292
The mechanism by which SLAP targets TCR  for degra-
dation has yet to be elucidated. Degradation of TCR  is likely to
involve the E3 ubiquitin ligase c-Cbl (Fig. 6). SLAP has been
previously reported to interact with the NH2 terminus of c-Cbl
(Tang et al., 1999). In addition, c-Cbl–deficient mice have a
very similar phenotype to SLAP-deficient mice with regard to
TCR–CD3, CD4, and CD5 up-regulation on DP thymocytes
and increases in positive selection (Naramura et al., 1998). Fi-
nally, TCR  has been previously shown to be ubiquitinated
(Cenciarelli et al., 1992, 1996; Hou et al., 1994), perhaps via
c-Cbl (Wang et al., 2001). Therefore, we suspect that the ubiquitin
ligase activity of c-Cbl is required to target TCR  for degrada-
tion and subsequently prevent the accumulation of recycling
TCR–CD3 complexes. Indeed, our unpublished results indicate
that c-Cbl and SLAP function in the same pathway to regulate
TCR–CD3 expression on DP thymocytes by targeting the TCR 
chain for degradation (unpublished data). Therefore, we suggest
the model shown in Fig. 6. Surface TCR–CD3 complexes in DP
thymocytes are constitutively phosphorylated on TCR  chains
by Lck. The TCR–CD3 complex is internalized and transported
to an intracellular compartment where SLAP binds to phos-
phorylated TCR , thus targeting TCR  for ubiquitination and
degradation via a c-Cbl–dependent mechanism. In the absence
of TCR , the remainder of the TCR–CD3 complex is either de-
graded or retained in an intracellular compartment. Conversely,
in the absence of SLAP, the TCR  is neither ubiquitinated nor
degraded, and the TCR–CD3 complex remains intact and con-
tinues to recycle back to the plasma membrane.
We have identified a novel mechanism by which TCR–
CD3 expression is regulated in a developmentally restricted
manner. Together with previous studies (Bonifacino et al., 1989,
1990; Kearse et al., 1995) that have implicated regulation of the
TCR–CD3 complex at the level of ER assembly is the current
mechanism of SLAP-mediated degradation of phospho-TCR –
containing complexes. It is interesting to speculate why DP thy-
mocytes possess multiple mechanisms to regulate surface TCR–
CD3 expression. We suspect that receptor levels are kept low on
DP thymocytes to ensure the selection of developing thymocytes
that express TCRs with the appropriate avidity for self-peptide–
MHC complexes. As a result of the massive amplification of the
TCR signaling cascade, it may be difficult for a thymocyte to
differentiate between strong and weak TCR signals if TCR levels
are high. Therefore, quantitative differences in signaling may be
more easily distinguished if levels of surface TCR–CD3 are kept
low. Likewise, the increase in receptor levels after positive selec-
tion may be desirable for a heightened sensitivity of thymocytes
to self-peptides that lead to negative selection. Such increases in
receptor levels could be achieved both by down-regulating
SLAP expression as well as by promoting TCR assembly. Thus,
SLAP may play a key role in regulating TCR–CD3 levels during
thymocyte development to optimize receptor levels for both pos-
itive and negative selection.
Materials and methods
Cell lines and plasmids 
Jurkat T cells, JCaM1, JCaM1   Lck, and P116 cell lines were maintained
in RPMI containing 5% FBS, 2 mM glutamine, penicillin, and streptomycin.
JCaM1 is an Lck /  Jurkat T cell line (Goldsmith and Weiss, 1987), and
JCaM1   Lck has been stably reconstituted with Lck (Straus and Weiss,
1992). P116 is a ZAP-70 /  Jurkat T cell line (Williams et al., 1998).
Plasmids encoding GFP, SLAP-GFP, and SH2-GFP were initially con-
structed by PCR amplification of WT or SH2 mutated murine SLAP from
pEF-BOS (Sosinowski et al., 2000) and ligation into pN1-GFP (CLON-
TECH Laboratories, Inc.) via EcoRI and BamHI sites. GFP constructs were
subcloned into pCDEF3 by using EcoRI and NotI sites.
Mice 
SLAP /  mice have been described previously (Sosinowski et al., 2001)
and have been backcrossed to a total of eight generations onto a C57BL/6
background. C57BL/6 mice (Taconic) were used as WT controls. ZAP-
70 /  mice have been previously described (Kadlecek et al., 1998).
TCR  /  mice were purchased from the Jackson Laboratory. TCR  Tg
and TCR  D67–250 were provided by E. Shores (Food and Drug Adminis-
tration, Bethesda, MD) and have been previously described (Shores et al.,
1994).
FACS staining 
After washing in PBS, thymocytes were stained with CD4 (RM4-5; eBio-
science), CD8  (53-6.7; BD Biosciences), CD3  (145-2C11; eBioscience),
and TCR  (H57-197; eBioscience) in FACS buffer (PBS with 1% BSA and
0.01% NaN3) for 30 min at 4 C. For intracellular FACS staining, thy-
mocytes were washed in PBS before fixation in 4% PFA for 20 min at RT.
After washing, thymocytes were permeabilized in 0.5% saponin in FACS
buffer for 20 min at RT. Thymocytes were stained with the antibodies listed
above in 0.5% saponin containing 1% goat serum for 30 min at 4 C. Jur-
kat T cells were stained with  -CD3  (UCHT1; BD Biosciences) in FACS
buffer for 30 min at 4 C. All FACS staining was performed in duplicate.
Internalization and degradation assays 
For ligand-induced CD3  internalization, surface CD3  was labeled with
biotinylated anti-CD3  antibodies (145-2C11) for 30 min on ice. Thy-
mocytes were washed, resuspended at 5   10
6 ml in primary cell culture
medium (RPMI containing 10% FBS, 2 mM glutamine, 50  M  -mercapto-
ethanol, penicillin, and streptomycin), and incubated at 37 C for the indi-
cated time points. Anti-CD3  remaining on the cell surface was detected
by staining with PE-conjugated streptavidin (Caltag Laboratories). For deg-
radation assays, thymocytes were cultured at 5   10
6 ml in primary cell
culture medium containing 100  g/ml cycloheximide. At each time point,
cells were mixed with 100  l ice-cold PBS containing 1% BSA and 0.1%
NaN3. Cells were maintained on ice for the remainder of the assay until
FACS staining.
Figure 6. TCR–CD3 complexes are endocytosed via clathrin-coated pits
and interact with SLAP in an intracellular compartment. TCR  is ubiquitinated
by c-Cbl and degraded. In the absence of TCR  chains, the remainder of
the TCR–CD3 complex is degraded. However, if SLAP fails to interact with
TCR , the TCR–CD3 complex remains intact and continues to recycle back
to the cell surface. p, phosphorylated TCR  chains.SLAP TARGETS TCR  FOR DEGRADATION • MYERS ET AL. 293
CD3  recycling
20   10
6 ml of freshly isolated thymocyte single-cell suspensions were cul-
tured at 37 C in primary cell culture media containing 5  g/ml PE-labeled
anti-CD3  (145-2C11). After 30 min in culture, thymocytes were washed
twice with PBS. Surface-bound antibody was removed by washing thy-
mocytes twice in ice-cold PBS containing 1% BSA, pH 1.5, followed by
immediate neutralization in FACS buffer. These conditions removed
 97% of cell surface staining. 5   10
6 ml of thymocytes were incubated
at 37 C in primary cell culture for the indicated time points. At each time
point, cells were mixed with 100  l of ice-cold PBS containing 1% BSA
and 0.1% NaN3 and were maintained on ice for the remainder of the as-
say. After all time points had been collected, thymocytes were again
washed twice in ice-cold PBS containing 1% BSA, pH 1.5, followed by im-
mediate neutralization in FACS buffer to remove anti-CD3  antibody that
was bound to recycled CD3 . Thymocytes were stained for CD4 and 8
and were analyzed by FACS. Recycled CD3  was calculated using the
following formula:
Labeling of recycling pool
Freshly isolated thymocyte single-cell suspensions were cultured at 20  
10
6 ml in primary cell culture media containing 100  g/ml cycloheximide
and 5  g/ml PE-labeled anti-CD3  (145-2C11) for 30 min on ice to fully
label surface CD3 . This was followed by a subsequent 60-min incubation
either on ice or at 37 C to achieve steady-state labeling of the recycling
pool. Cells were washed, stained for CD4 and 8 expression, and ana-
lyzed by FACS.
Hypertonic recycling assay
10
6 ml Jurkat T cells (in RPMI) or 5   10
6 ml of freshly isolated thymocyte
single-cell suspensions (in primary cell culture media) were incubated with
0.45 M sucrose. At each time point, cells were mixed with 100  l of ice-
cold PBS containing 1% BSA and 0.1% NaN3. Cells were maintained on
ice for the remainder of the assay until FACS staining.
Inhibition of clathrin-mediated endocytosis was measured by the in-
hibition of transferrin uptake. Jurkat T cells were incubated on ice with
Alexa647-labeled transferrin (Molecular Probes) for 20 min to allow for
transferrin binding. Excess transferrin was washed off with three washes in
ice-cold PBS. Cells were resuspended in RPMI   0.45 M sucrose and
were incubated either on ice or at 37 C for 10 min. After incubation, cells
were transferred into ice-cold PBS containing 1% BSA and 0.1% NaN3
and rested for 1 h on ice. Surface-bound transferrin was competed off by
using a 50-fold excess of unlabeled transferrin (Sigma-Aldrich) in FACS
buffer for 30 min at RT. Internalized transferrin was calculated by using
the following formula:
where background represents the remaining fluorescence that was present
on competed samples incubated on ice.
Western blotting and immunoprecipitations
For total levels of TCR , CD3 , and TCR , CD8  thymocytes were puri-
fied by using magnetic cell sorting (Miltenyi Biotec) according to the man-
ufacturer’s protocol. Recovered cells were  95% DP, as assessed by
FACS. CD8  thymocytes were lysed at 200   10
6 ml in radioimmunopre-
cipitation (RIPA) lysis buffer supplemented with protease inhibitors (leupep-
tin, aprotinin, PMSF, and pepstatin A) for 30 min on ice. Postnuclear su-
pernatants were prepared by centrifuging samples at 16,000 g (4 C) for
30 min. For TCR , postnuclear supernatants from 50   10
6 cell equiva-
lents were immunoprecipitated with  -TCR  (H-142; Santa Cruz Biotech-
nology, Inc.) and protein G (GE Healthcare) for 1 h at 4 C. Samples were
washed four times with lysis buffer, resuspended in SDS loading buffer,
and boiled for 5 min. For CD3  and TCR , postnuclear supernatants from
5   10
6 cell equivalents were mixed with SDS loading buffer and were
boiled. Samples were electrophoresed in a 12.5% SDS-PAGE gel, trans-
ferred to Immobilon, and blotted for  -tubulin (B-5-1-2; Sigma-Aldrich),
TCR  (H-142), CD3  (M20; Santa Cruz Biotechnology, Inc.), or TCR 
(8D3; BD Biosciences). Subsequently, membranes were incubated in sec-
ondary antibodies coupled to HRP (GE Healthcare) and were detected by
using enhanced chemiluminescence (GE Healthcare). For TCR–CD3 deg-
radation experiments, CD8  thymocytes were cultured in primary cell cul-
ture media containing 100  g/ml cycloheximide. At each time point, thy-
% Recycled 100 MFI at t = 0 () MFI at time point () –
MFI at t = 0
--------------------------------------------------------------------------------------- × . =
% Internalized MFI of competed  sample background MFI –
MFI of uncompeted sample background MFI –
-----------------------------------------------------------------------------------------------------------------, =
mocytes were lysed in RIPA lysis buffer and were maintained on ice for the
remainder of the experiment. Lysates were blotted for  -tubulin, TCR ,
CD3 , or TCR  as described above. Western blots were quantitated on an
Image Station (Eastman Kodak Co.) using 1D Image Analysis software
version 3.5 (Eastman Kodak Co.).
For SLAP/TCR  coimmunoprecipitations, cells were transiently trans-
fected with GFP, SLAP-GFP, or SH2-GFP overnight. Cells were washed twice
in PBS and were lysed at 50   10
6 ml in RIPA lysis buffer as described
above (but supplemented with NaVO4). Postnuclear supernatants from
60   10
6 cells were immunoprecipitated with TCR  (6B10.2; Santa Cruz
Biotechnology, Inc.) and protein G as described above. Samples were elec-
trophoresed in a 12.5% SDS-PAGE gel, transferred to Immobilon, and blot-
ted for GFP (JL8; CLONTECH Laboratories, Inc.) or phosphotyrosine (4G10;
Upstate Biotechnology) as described for Western blotting. Subsequently,
membranes were stripped (30 min at 55 C in 5% SDS, 100 mM  -mercap-
toethanol, and 62.5 mM Tris, pH 6.8) and blotted for TCR  (8D3; BD Bio-
sciences). In some experiments, transfected cells were incubated overnight
with 20  M PP2 (Calbiochem) to inhibit Src family kinase activity.
Metabolic labeling 
80   10
6 freshly isolated thymocytes were cultured for 30 min in 4 ml cys-
teine and methionine-free media (Biofluids) at 37 C. Thymocytes were la-
beled with 2 mCi of Tran
35SLabel (ICN Biomedicals) for 30 min at 37 C.
Cells were washed, lysed in RIPA lysis buffer as described above, and
precleared for 30 min at 4 C with protein G. Lysates were immunoprecip-
itated for TCR  (H-142), CD3  (M-20), or TCR  (6B10.2), run on an SDS-
PAGE gel, and transferred to Immobilon as described above. Half of each
immunoprecipitate was used to detect the Tran
35SLabel. The other half of
the immunoprecipitate was Western blotted (as described above) as a
loading control.
Immunofluorescence
Jurkat T cells were transfected with GFP, SLAP-GFP, or SH2-GFP overnight.
Transfected cells were washed and allowed to settle onto poly-L-lysine–
coated plates. Samples were fixed in 4% PFA (20 min at RT) and were
permeabilized with 0.1% Triton X-100 (10 min at RT). Samples were incu-
bated in blocking buffer (PBS with 0.5% BSA, 0.5% milk, and 1% goat se-
rum) for 10 min at RT and were incubated in primary antibody (6B10.2,
1:50) in blocking buffer for 2 h at 37 C. After washing, samples were in-
cubated in secondary antibody (Cy5 goat anti–mouse IgG; Jackson Immu-
noResearch Laboratories) in blocking buffer for 20 min at RT. Samples
were washed, coverslipped in gel/mount (Biomeda), and visualized on a
turnkey inverted digital microscopy system (Marianas; Intelligent Imaging)
that was built around an inverted microscope (Axiovert 200M; Carl Zeiss
MicroImaging, Inc.) using a plan-Neofluar 40  oil immersion objective
(NA 1.3; Carl Zeiss MicroImaging, Inc.). Images were collected at RT with
a CCD SensiCam (PCD; Cooke Corp.) using SlideBook software (Intelli-
gent Imaging), were deconvolved using a constrained iterative algorithm
(SlideBook), and were exported as TIFF files.
We would like to thank Tomasz Sosinowski for advice and generation of
SLAP-deficient mice, Elizabeth Shores for providing TCR -transgenic mice,
Dario Vignali and Jeroen Roose for critical reading of the manuscript, and
Frances Brodsky, Mark von Zastrow, and members of the Weiss lab for ad-
vice and suggestions.
Submitted: 31 January 2005
Accepted: 15 June 2005
References
Bonifacino, J.S., C.K. Suzuki, J. Lippincott-Schwartz, A.M. Weissman, and
R.D. Klausner. 1989. Pre-Golgi degradation of newly synthesized T-cell
antigen receptor chains: intrinsic sensitivity and the role of subunit as-
sembly. J. Cell Biol. 109:73–83.
Bonifacino, J.S., S.A. McCarthy, J.E. Maguire, T. Nakayama, D.S. Singer, R.D.
Klausner, and A. Singer. 1990. Novel post-translational regulation of
TCR expression in CD4 CD8  thymocytes influenced by CD4. Nature.
344:247–251.
Cenciarelli, C., D. Hou, K.C. Hsu, B.L. Rellahan, D.L. Wiest, H.T. Smith, V.A.
Fried, and A.M. Weissman. 1992. Activation-induced ubiquitination of
the T cell antigen receptor. Science. 257:795–797.
Cenciarelli, C., K.G. Wilhelm Jr., A. Guo, and A.M. Weissman. 1996. T cell an-
tigen receptor ubiquitination is a consequence of receptor-mediated ty-
rosine kinase activation. J. Biol. Chem. 271:8709–8713.JCB • VOLUME 170 • NUMBER 2 • 2005 294
Chen, C., J.S. Bonifacino, L.C. Yuan, and R.D. Klausner. 1988. Selective degrada-
tion of T cell antigen receptor chains retained in a pre-Golgi compartment.
J. Cell Biol. 107:2149–2161.
D’Oro, U., I. Munitic, G. Chacko, T. Karpova, J. McNally, and J.D. Ashwell.
2002. Regulation of constitutive TCR internalization by the zeta-chain.
J. Immunol. 169:6269–6278.
Dallanegra, A., L. Schaffar, J.P. Breittmayer, J.L. Carpentier, and M. Fehlmann.
1988. Effect of hypertonicity and monensin on CD3/TCR surface ex-
pression in human T cells. Immunol. Lett. 19:115–120.
Daukas, G., and S.H. Zigmond. 1985. Inhibition of receptor-mediated but not
fluid-phase endocytosis in polymorphonuclear leukocytes. J. Cell Biol.
101:1673–1679.
Ericsson, P.O., and H.S. Teh. 1995. The protein tyrosine kinase p56lck regulates
TCR expression and T cell selection. Int. Immunol. 7:617–624.
Exley, M., C. Terhorst, and T. Wileman. 1991. Structure, assembly and intracellu-
lar transport of the T cell receptor for antigen. Semin. Immunol. 3:283–297.
Finkel, T.H., M. McDuffie, J.W. Kappler, P. Marrack, and J.C. Cambier. 1987.
Both immature and mature T cells mobilize Ca2  in response to antigen
receptor crosslinking. Nature. 330:179–181.
Goldsmith, M.A., and A. Weiss. 1987. Isolation and characterization of a
T-lymphocyte somatic mutant with altered signal transduction by the an-
tigen receptor. Proc. Natl. Acad. Sci. USA. 84:6879–6883.
Havran, W.L., M. Poenie, J. Kimura, R. Tsien, A. Weiss, and J.P. Allison. 1987.
Expression and function of the CD3-antigen receptor on murine
CD4 8  thymocytes. Nature. 330:170–173.
Heuser, J.E., and R.G. Anderson. 1989. Hypertonic media inhibit receptor-
mediated endocytosis by blocking clathrin-coated pit formation. J. Cell
Biol. 108:389–400.
Hou, D., C. Cenciarelli, J.P. Jensen, H.B. Nguygen, and A.M. Weissman. 1994.
Activation-dependent ubiquitination of a T cell antigen receptor subunit
on multiple intracellular lysines. J. Biol. Chem. 269:14244–14247.
Irving, B.A., F.W. Alt, and N. Killeen. 1998. Thymocyte development in the
absence of pre-T cell receptor extracellular immunoglobulin domains.
Science. 280:905–908.
Iwashima, M., B.A. Irving, N.S. van Oers, A.C. Chan, and A. Weiss. 1994. Se-
quential interactions of the TCR with two distinct cytoplasmic tyrosine
kinases. Science. 263:1136–1139.
Kadlecek, T.A., N.S. van Oers, L. Lefrancois, S. Olson, D. Finlay, D.H. Chu,
K. Connolly, N. Killeen, and A. Weiss. 1998. Differential require-
ments for ZAP-70 in TCR signaling and T cell development. J. Immunol.
161:4688–4694.
Kearse, K.P., D.L. Wiest, and A. Singer. 1993. Subcellular localization of
T-cell receptor complexes containing tyrosine-phosphorylated zeta pro-
teins in immature CD4 CD8  thymocytes. Proc. Natl. Acad. Sci.
USA. 90:2438–2442.
Kearse, K.P., Y. Takahama, J.A. Punt, S.O. Sharrow, and A. Singer. 1995. Early
molecular events induced by T cell receptor (TCR) signaling in imma-
ture CD4  CD8  thymocytes: increased synthesis of TCR-  protein is
an early response to TCR signaling that compensates for TCR-  instabil-
ity, improves TCR assembly, and parallels other indicators of positive
selection. J. Exp. Med. 181:193–202.
Kishimoto, H., R.T. Kubo, H. Yorifuji, T. Nakayama, Y. Asano, and T. Tada.
1995. Physical dissociation of the TCR-CD3 complex accompanies re-
ceptor ligation. J. Exp. Med. 182:1997–2006.
La Gruta, N.L., H. Liu, S. Dilioglou, M. Rhodes, D.L. Wiest, and D.A. Vignali.
2004. Architectural changes in the TCR:CD3 complex induced by MHC:
peptide ligation. J. Immunol. 172:3662–3669.
Lippincott-Schwartz, J., J.S. Bonifacino, L.C. Yuan, and R.D. Klausner. 1988.
Degradation from the endoplasmic reticulum: disposing of newly syn-
thesized proteins. Cell. 54:209–220.
Liu, H., M. Rhodes, D.L. Wiest, and D.A. Vignali. 2000. On the dynamics of TCR:
CD3 complex cell surface expression and downmodulation. Immunity.
13:665–675.
Love, P.E., and A.C. Chan. 2003. Regulation of thymocyte development: only
the meek survive. Curr. Opin. Immunol. 15:199–203.
Manes, G., P. Bello, and S. Roche. 2000. Slap negatively regulates Src mito-
genic function but does not revert Src-induced cell morphology changes.
Mol. Cell. Biol. 20:3396–3406.
Mellman, I. 1996. Endocytosis and molecular sorting. Annu. Rev. Cell Dev.
Biol. 12:575–625.
Menne, C., T. Moller Sorensen, V. Siersma, M. von Essen, N. Odum, and C.
Geisler. 2002. Endo- and exocytic rate constants for spontaneous and
protein kinase C-activated T cell receptor cycling. Eur. J. Immunol.
32:616–626.
Molina, T.J., K. Kishihara, D.P. Siderovski, W. van Ewijk, A. Narendran, E.
Timms, A. Wakeham, C.J. Paige, K.U. Hartmann, A. Veillette, et al.
1992. Profound block in thymocyte development in mice lacking p56lck.
Nature. 357:161–164.
Nakayama, T., A. Singer, E.D. Hsi, and L.E. Samelson. 1989. Intrathymic sig-
nalling in immature CD4 CD8  thymocytes results in tyrosine phos-
phorylation of the T-cell receptor zeta chain. Nature. 341:651–654.
Naramura, M., H.K. Kole, R.J. Hu, and H. Gu. 1998. Altered thymic positive se-
lection and intracellular signals in Cbl-deficient mice. Proc. Natl. Acad.
Sci. USA. 95:15547–15552.
Negishi, I., N. Motoyama, K. Nakayama, S. Senju, S. Hatakeyama, Q. Zhang,
A.C. Chan, and D.Y. Loh. 1995. Essential role for ZAP-70 in both posi-
tive and negative selection of thymocytes. Nature. 376:435–438.
Ono, S., H. Ohno, and T. Saito. 1995. Rapid turnover of the CD3 zeta chain inde-
pendent of the TCR-CD3 complex in normal T cells. Immunity. 2:639–644.
Pandey, A., H. Duan, and V.M. Dixit. 1995. Characterization of a novel Src-
like adapter protein that associates with the Eck receptor tyrosine kinase.
J. Biol. Chem. 270:19201–19204.
Roche, S., G. Alonso, A. Kazlauskas, V.M. Dixit, S.A. Courtneidge, and A.
Pandey. 1998. Src-like adaptor protein (Slap) is a negative regulator of
mitogenesis. Curr. Biol. 8:975–978.
Schmid, S.L. 1997. Clathrin-coated vesicle formation and protein sorting: an in-
tegrated process. Annu. Rev. Biochem. 66:511–548.
Sebzda, E., S. Mariathasan, T. Ohteki, R. Jones, M.F. Bachmann, and P.S.
Ohashi. 1999. Selection of the T cell repertoire. Annu. Rev. Immunol.
17:829–874.
Shores, E.W., K. Huang, T. Tran, E. Lee, A. Grinberg, and P.E. Love. 1994.
Role of TCR zeta chain in T cell development and selection. Science.
266:1047–1050.
Sosinowski, T., A. Pandey, V.M. Dixit, and A. Weiss. 2000. Src-like adaptor pro-
tein (SLAP) is a negative regulator of T cell receptor signaling. J. Exp.
Med. 191:463–474.
Sosinowski, T., N. Killeen, and A. Weiss. 2001. The Src-like adaptor protein
downregulates the T cell receptor on CD4 CD8  thymocytes and regu-
lates positive selection. Immunity. 15:457–466.
Straus, D.B., and A. Weiss. 1992. Genetic evidence for the involvement of the lck
tyrosine kinase in signal transduction through the T cell antigen receptor.
Cell. 70:585–593.
Szymczak, A.L., and D.A. Vignali. 2005. Plasticity and rigidity in adaptor pro-
tein-2-mediated internalization of the TCR:CD3 complex. J. Immunol.
174:4153–4160.
Tang, J., S. Sawasdikosol, J.H. Chang, and S.J. Burakoff. 1999. SLAP, a
dimeric adapter protein, plays a functional role in T cell receptor signaling.
Proc. Natl. Acad. Sci. USA. 96:9775–9780.
Telerman, A., R.B. Amson, F. Romasco, J. Wybran, P. Galand, and R. Mossel-
mans. 1987. Internalization of human T lymphocyte receptors. Eur. J.
Immunol. 17:991–997.
Thien, C.B., R.M. Scaife, J.M. Papadimitriou, M.A. Murphy, D.D. Bowtell, and
W.Y. Langdon. 2003. A mouse with a loss-of-function mutation in the
c-Cbl TKB domain shows perturbed thymocyte signaling without enhanc-
ing the activity of the ZAP-70 tyrosine kinase. J. Exp. Med. 197:503–513.
van Oers, N.S., N. Killeen, and A. Weiss. 1994. ZAP-70 is constitutively associ-
ated with tyrosine-phosphorylated TCR zeta in murine thymocytes and
lymph node T cells. Immunity. 1:675–685.
van Oers, N.S., N. Killeen, and A. Weiss. 1996. Lck regulates the tyrosine
phosphorylation of the T cell receptor subunits and ZAP-70 in murine
thymocytes. J. Exp. Med. 183:1053–1062.
Wang, H.Y., Y. Altman, D. Fang, C. Elly, Y. Dai, Y. Shao, and Y.C. Liu. 2001.
Cbl promotes ubiquitination of the T cell receptor zeta through an adap-
tor function of Zap-70. J. Biol. Chem. 276:26004–26011.
Williams, B.L., K.L. Schreiber, W. Zhang, R.L. Wange, L.E. Samelson, P.J.
Leibson, and R.T. Abraham. 1998. Genetic evidence for differential cou-
pling of Syk family kinases to the T-cell receptor: reconstitution studies
in a ZAP-70-deficient Jurkat T-cell line. Mol. Cell. Biol. 18:1388–1399.